nitric oxide synthase; syncope; orthostatic hypotension; spaceflight; weightlessness; astronauts PROLONGED EXPOSURE TO MICROGRAVITY during spaceflight or extended bed rest on Earth results in cardiovascular deconditioning, which is marked by orthostatic intolerance and impaired exercise capacity on reexposure to gravity (6, 52) . Gravitational forces on Earth promote a normal shift of the extracellular fluids to the lower parts of the body. The effect of gravity on extracellular fluid distribution is evidenced by the presence of a pronounced gradient in mean arterial blood pressure between the head (ϳ70 mmHg) and feet (ϳ200 mmHg) during upright posture in normal humans on Earth (12) . Exposure to microgravity leads to an immediate redistribution of extracellular fluid to the upper half of the body, as evidenced by the rise in mean arterial blood pressure in the head, from ϳ70 mmHg on Earth to ϳ100 mmHg in space (12) . This results in an early rise and a later fall in central venous pressure and development of hypovolemia, resting tachycardia, and diminished stroke volume in chronic phase (52) . The upward shift in extracellular fluid distribution appears to be responsible for the cardiovascular adaptation to microgravity. This viewpoint is supported by the observation that a cardiovascular deconditioning similar to that seen in returning astronauts occurs in humans kept in a supine position with a 6% head-down tilt on Earth (52) .
Under normal conditions, assumption of the upright position is accompanied by a significant vasoconstriction in the lower extremities. This helps to maintain blood pressure and flow in the upper part of the body, including the brain, by mitigating the gravitational shift of blood to the lower parts of the body. However, the physiological response is impaired in microgravityadapted individuals, such as the returning astronauts who experience marked orthostatic hypotension and an increased propensity to syncope (52) . This is, in part, due to hypovolemia and impaired vasoconstrictive response in such individuals (5) .
Hindlimb unloading (HU) in rodents has been used as a model to simulate cardiovascular deconditioning in humans. This model exhibits many of the known cardiovascular consequences of microgravity in humans, including extracellular fluid redistribution, altered central venous pressure, hypovolemia, and reduced exercise capacity (8) . Likewise, the HU animals exhibit a depressed vasoconstrictive response to norepinephrine (31) and other vasoconstrictors (8) .
Nitric oxide (NO) is an endogenous modulator, which is produced by various cell types in different tissues and which regulates numerous biological processes. For instance, NO is the most potent endogenous vasodilator and as such plays an important role in the regulation of renal and systemic vascular resistance, tissue perfusion, and renal hemodynamics. In addition, NO inhibits renal tubular sodium reabsorption (17-19, 21, 30, 32, 33, 36, 37, 44, 45) and as such contributes to sodium and extracellular fluid volume homeostasis. Through these mechanisms, NO plays an important role in the regulation of blood pressure.
In an earlier study, we found functional evidence for an HU-induced increase in vascular NO activity (34) . This was based on the observation that endotheliummediated vasodilatory activity was increased in carotid arteries and the vasodilatory response to L-arginine was increased in the femoral arteries of the HU rats. Moreover, the vasodilatory response to L-arginine could be blocked by the inducible nitric oxide synthase (iNOS)-selective inhibitor, aminoguanidine, pointing to a possible rise in vascular iNOS activity. These observations led to the hypothesis of the present study that extended exposure to microgravity can lead to a general upregulation of the NO system. This hypothesis was addressed using the HU rat to simulate microgravity.
METHODS

Animal Model
The protocol employed in this study was approved by the Institutional Animal Care and Use Committee of the University of California, Irvine. Male Wistar rats weighing 250-300 g (Simonsen Laboratories, Gilroy, CA) were housed in a climate-controlled room (22°C) with a 12:12-h light-dark cycle. Water and rat chow were provided ad libitum. Animals were randomly assigned to control or HU groups. HU was achieved by the use of a tail harness that partially elevated the hindlimbs above the floor of the cage (31, 39) . Briefly, the tail was cleaned, and a coat of benzoin tincture was applied and allowed to air dry until tacky. Adhesive strips (Fas-Trac of California, Van Nuys, CA) the width of the tail were then looped through a swivel harness and pressed along the sides of the tail to form a tubular casing around the tail. Thereafter, the tail was wrapped with Electoplast bandage (Beiersdorf, Norwalk, CT) followed by a thin layer of plaster cast material (Sammons Preston, Bolingbrook, IL). The rat was suspended by the swivel harness from a hook at the top center of the suspension cage, allowing a free 360°rotation. The height of the hook was adjusted such that the front limbs were in contact with the floor, and the hindlimbs were elevated ϳ0.5 cm above the floor when fully extended, tilting the body of the rat to an angle of 35°with the floor of the cage. The animals were exposed to HU for 20 days. At the conclusion of the 20-day observation period, subgroups of HU and control animals (n ϭ 6 in each group) were used for determinations of blood pressure response to norepinephrine and aminoguanidine as described below. A second subgroup of six HU animals and six control rats were killed, and tissues were harvested for determination of NOS isotypes.
The rats were killed by exposure to 100% CO 2 for 90 s to induce deep anesthesia (10) . The chest and abdomen were opened, and the heart, thoracic aorta, kidney, and brain were removed, cleaned in PBS, snap frozen in liquid nitrogen, and stored at Ϫ70°C until processed.
Response to Norepinephrine and Aminoguanidine
Under general anesthesia with Inactin (100 mg/kg ip), the left jugular vein and carotid artery were cannulated with polyethylene tubes (PE-50). The animal was placed on a heating pad, and arterial blood pressure was monitored directly via the arterial catheter that was connected to a Gould P-50 pressure transducer and recorded on a Dynograph R511A recorder (Sensor Medics, Anaheim, CA). Once stable, blood pressure was continuously recorded for 5 min to determine the baseline value. Subsequently, pressor responses to bolus injections of norepinephrine (0.15 g/kg; Sigma Chemical, St. Louis, MO) and the iNOS inhibitor aminoguanidine (30 mg/kg; Sigma Chemical) were determined. Response to each drug was calculated as peak change in blood pressure from the baseline value. Mean arterial pressure was calculated as the sum of diastolic blood pressure and one-third of the pulse pressure. Each drug was injected at least twice, and the average of the values obtained was used. A 30-min recovery period was allowed after each bolus injection of norepinephrine. However, the aminoguanidine injections were separated by a 60-min interval.
NOS Protein Measurements
Homogenates (25% wt/vol) of kidney, heart (left ventricle), thoracic aorta, and brain were prepared in 10 mM HEPES buffer, pH 7.4, containing 320 mM sucrose, 1 mM EDTA, 1 mM dithiothreitol (DTT), 10 g/ml leupeptin, and 2 g/ml aprotinin at 0-4°C with the aid of a tissue grinder fitted with a motor-driven ground glass pestle. Homogenates were centrifuged at 12,000 g for 5 min at 4°C to remove nuclear fragments and tissue debris without precipitating plasma membrane fragments. The supernatant was used for determination of NOS isotype proteins. Total protein concentration was determined by using a kit from Bio-Rad Laboratories (Hercules, CA).
Endothelial NOS (eNOS), neuronal NOS (nNOS), and iNOS proteins were measured by Western blot analyses using anti-eNOS, anti-nNOS, and anti-iNOS monoclonal antibodies (Transduction Laboratories, Lexington, KY) in a manner the same as that previously described by Vaziri et al. (48, 49) . Briefly, aorta, kidney, heart, and brain tissue preparations (50 g of protein for aorta and brain and 100 g for kidney and heart) were size-fractionated on 4-12% Trisglycine gel (Novex, San Diego, CA) at 120 V for 3 h. In preliminary experiments, we had found that the given protein concentrations were within the linear range of detection for our Western blot technique. After electrophoresis, proteins were transferred onto Hybond-enhanced chemiluminescence (ECL) membrane (Amersham Life Science, Arlington Heights, IL) at 400 mA for 120 min using the Novex transfer system. The membrane was prehybridized in 10 ml of buffer A (10 mM Tris-hydrochloride, pH 7.5, 100 mM NaCl, 0.1% Tween 20, and 10% nonfat milk powder) for 1 h and then hybridized for an additional 1-h period in the same buffer containing 10 l of the given anti-NOS monoclonal antibody (1:1,000). The membrane was then washed for 30 min in a shaking bath, changing the wash buffer (buffer A without nonfat milk) every 5 min before the 1-h incubation in buffer A plus goat anti-mouse IgG-horseradish peroxidase at the final titer of 1:1,000. Experiments were carried out at room temperature. The washes were repeated before the membrane was developed with a light-emitting nonradioactive method using ECL reagent (Amersham Life Science). The membrane was then subjected to autoluminography for 1-5 min. The autoluminographs were scanned with a laser densitometer (model PD1211, Molecular Dynamics, Sunnyvale, CA) to determine the relative optical densities of the bands. In all instances, the membranes were stained with Ponceau stain, which verified the uniformity of protein load and transfer efficiency across the test samples.
Measurement of Tissue Nitrate Plus Nitrite
Kidney tissues (25%, wt/vol) were homogenized in 10 mM HEPES buffer, pH 7.4, containing 1 mM EDTA, 1 mM DTT, 10 g/ml leupeptin, and 2 g/ml aprotinin at 0-4°C with the aid of a Polytron homogenizer. Homogenates were centrifuged at 12,000 g for 5 min at 4°C, and the supernatant was used for the determination of total nitrate plus nitrite (NOx) using the purge system of a Sievers Instruments model 270B NO analyzer (Boulder, CO) as described previously (50) .
Data Analysis
Regression analysis and a t-test were used in the statistical analysis of the data, which are presented as means Ϯ SE. P values Յ0.05 were considered significant.
RESULTS
NOS Isotype Values
Aorta. iNOS and eNOS proteins were detectable in the aorta tissue preparations in both groups. The HU group exhibited a marked upregulation of iNOS protein expression in the aorta compared with the control group (P Ͻ 0.01). In contrast, aorta eNOS protein in the HU group was similar to that found in the control group (Fig. 1) .
Heart. Both iNOS and eNOS proteins were expressed in the cardiac tissues of the study animals. Compared with the control group, the HU group showed a significant increase in heart tissue iNOS protein abundance (P Ͻ 0.05). However, no significant difference was found in cardiac tissue eNOS abundance between the HU and the control group (Fig. 2) .
Kidney. Immunodetectable eNOS, iNOS, and nNOS proteins were present in the renal tissue preparations of all animals. As with the heart and aorta, kidney iNOS expression was significantly increased (P Ͻ 0.01) in the HU group. In addition, nNOS protein abundance was significantly elevated in the HU animals when compared with that found in the control group (P Ͻ 0.01). However, as with the other tissues, kidney eNOS protein expression was unaffected by HU treatment. Data are illustrated in Fig. 3 .
Brain. Determination of nNOS protein revealed a significant elevation of nNOS protein abundance in the brain of HU animals compared with that in the control group (P Ͻ 0.01). Data are depicted in Fig. 4 .
Tissue NOx Level
Kidney tissue NOx content in the HU group (1.08 Ϯ 0.08 nmol/mg protein) was significantly higher than that found in the control group (0.77 Ϯ 0.06 nmol/mg protein, P Ͻ 0.05). A significant correlation was found between kidney tissue NOx content and kidney tissue iNOS (r ϭ 0.809, P Ͻ 0.05) and nNOS (r ϭ 0.902, P Ͻ 0.01) but not eNOS [r ϭ 0.112, P ϭ not significant (NS)].
Response to Norepinephrine and Aminoguanidine
Baseline systolic arterial blood pressure in the HU group (140 Ϯ 20 mmHg) was not significantly different from that seen in the control group (147 Ϯ 15 mmHg, P ϭ NS). Likewise, baseline heart rates were comparable in the two groups (442 Ϯ 19 beats/min and 439 Ϯ 22 beats/min, respectively, P ϭ NS). Norepinephrine administration resulted in an expected rise in arterial blood pressure in both groups. However, the HU group exhibited a significant attenuation of hypertensive response to norepinephrine administration compared with that seen in the control group (P Ͻ 0.01). Administration of the iNOS inhibitor aminoguanidine resulted in a significant rise in blood pressure in both groups. However, aminoguanidine administration elicited a significantly greater pressor response in the HU group compared with that in the control group (Fig. 5) . These findings point to enhanced iNOS activity and Fig. 1 . Representative Western blots (3 animals from each group) and group data (n ϭ 6 in each group) depicting aorta endothelial nitric oxide synthase (eNOS, top) and inducible NOS (iNOS, bottom) protein abundance in the hindlimb unloaded (HU) and control (CTL) groups. ** P Ͻ 0.01 provide functional evidence for the observed increase in iNOS abundance in the HU group.
DISCUSSION
The HU group exhibited a significant upregulation of iNOS protein expression in the aorta, heart, and the kidney. This was accompanied by increased nNOS protein expression in the brain and the kidney in the HU group. However, eNOS abundance was not altered by chronic HU in our animals. The elevation of renal iNOS and nNOS proteins was accompanied by a significant increase in the renal tissue content of stable NO metabolites (NOx). This observation points to increased NO production in the kidney. In fact, renal tissue NOx was significantly related to the corresponding iNOS and nNOS levels, which were elevated, but not with eNOS, which was unaffected by HU.
According to the traditional view, iNOS is not expressed under physiological conditions. Instead, iNOS is induced under certain pathological conditions, namely, during inflammatory states and, most dramatically, in septic shock. iNOS can also be induced experimentally both in vivo and in vitro by endotoxin and the proinflammatory cytokines, tumor necrosis factor-␣, interleukin-1␤, and interferon-␥ (38) . In addition to the classic induction pathway noted above, a lowlevel constitutive expression of iNOS has been recently demonstrated in several tissues, including kidney, heart, and blood vessel wall under normal conditions (1, 23, 24, 29) . Moreover, dysregulation of constitutively expressed iNOS has been reported in several clinical and experimental conditions associated with disturbances of blood pressure, fluid, and electrolytes (27, 35, (47) (48) (49) . For instance, we have shown downregulation of renal and vascular tissue iNOS in uremic Fig. 3 . Representative Western blots (3 animals from each group) and the corresponding group data (n ϭ 6 rats in each group) illustrating eNOS (top), iNOS (middle), and neuronal NOS (nNOS; bottom) abundances in the kidney tissue preparations from the HU and the control groups. ** P Ͻ 0.01 Fig. 2 . Representative Western blots (3 animals from each group) and group data (n ϭ 6 rats in each group) depicting heart eNOS (top) and iNOS (bottom) protein abundance in the HU and control groups. * P Ͻ 0.05 rats, cyclosporine-treated animals, and Dahl salt-sensitive rats (27, 48, 49) , models which are characterized by hypertension and salt retention. In contrast, we have found marked upregulation of renal and vascular iNOS expression in young spontaneously hypertensive rats wherein hypertension is not associated with salt retention (47) . Thus low-level constitutive expression of iNOS plays a physiologically regulatory role that is distinct from classic endotoxin/cytokine-mediated induction of iNOS leading to massive release of NO and other reactive species, hypotension, and cytotoxicity. We believe that upregulation of renal, vascular, and cardiac iNOS expression and of renal and brain nNOS expression in the HU group contributes to adaptation to simulated microgravity and the resulting cardiovascular deconditioning in this model. This viewpoint is supported by the observation that the HU animals exhibited a significantly greater hypertensive response to administration of the reputed iNOS inhibitor, aminoguanidine, than did the control group. The observed pressor response in the HU group points to increased iNOS-derived NO production in these animals, thus providing functional evidence for the observed increase in iNOS protein abundance. Together, these findings support the role of upregulation of iNOS expression in the adaptive vasodilatory response to simulated microgravity and hyporesponsiveness to vasoconstrictive agents previously shown by Purdy et al. (31, 34) and Delp et al. (8) and confirmed in the present study. Moreover, we have recently reported functional evidence suggesting that iNOS activity is elevated in the femoral artery of HU rats (34) .
Aminoguanidine was used because it demonstrated selectivity for iNOS over eNOS and nNOS. For example, in our earlier study (34) , 100 M aminoguanidine had no effect on acetylcholine-mediated, endotheliumdependent relaxation of isolated arteries. Moreover, Wolff and Lubeskie (55) showed that aminoguanidine is 50-500 times more selective for iNOS over nNOS. In the present study, we measured NOS isotypes in the thoracic aorta, which is a conduit artery. Although small resistance arteries would have been more desirable, their use in this assay, which requires a substantial amount of tissue for protein extraction, was impractical. It is of interest that changes of eNOS and iNOS in the kidney and heart, tissues that are replete with resistance arteries and arterioles, paralleled those found in the aorta of HU animals. This observation suggests that findings in the aorta may mirror those of the small arteries and arterioles, which are the primary target of NO. Immunohistological studies are required to confirm this supposition.
In addition to upregulation of iNOS, the HU animals employed in the present study exhibited a marked upregulation of kidney nNOS protein expression. nNOS is normally expressed in different parts of the kidney, particularly in macula densa and endothelia of efferent arteriole (2, 25, 44, 54) . nNOS-derived NO plays an important role in modulation of renal microvascular function and tubuloglomerular feedback (13-15, 20, 28, 40, 41, 46, 53) . In addition, renal iNOSderived NO is thought to play an important role in renal sodium handling. For instance, conditions marked by impaired renal sodium handling and salt sensitivity such as seen in Dahl salt-sensitive rats (27) , cyclosporine-induced hypertension (49) , and chronic renal failure (48) are accompanied by depressed iNOS expression in the kidney and other tissues. It is, therefore, conceivable that upregulations of renal iNOS and nNOS may facilitate renal sodium excretion and thus contribute to natriuresis and hypovolemia, which are known consequences of extended exposure to microgravity. Fig. 4 . Representative Western blot (3 animals from each group) and group data (n ϭ 6 rats in each group) depicting brain nNOS protein abundance in the HU and control groups. ** P Ͻ 0.01 The HU animals employed in the present study exhibited a marked upregulation of brain nNOS abundance. nNOS is normally expressed in various regions of the brain and is thought to be involved in neurogenic control of blood pressure by inhibiting central sympathetic outflow (4, 11, 43, 51) . Consequently, nNOSderived NO in the brain is considered to exert a blood pressure-lowering influence. If true, upregulation of brain nNOS may potentially contribute to orthostatic intolerance by suppressing the central sympathetic outflow following extended exposure to microgravity. In support of this notion, Moffitt et al. (22) have recently shown a marked attenuation of basal lumbar and renal sympathetic nerve activities in the HU animals compared with the control rats. They have further demonstrated a significant attenuation of lumbar and renal sympathetic system activity in response to a hypotensive challenge in these animals (22) . It is of interest that brain nNOS expression is increased in various models of hypertension, including rats with chronic renal failure (56), salt-loaded, salt-sensitive Dahl rats (27) , and rats with aortic coarctation-induced hypertension (3). These observations suggest the possible role of elevated pressure in regulation of brain nNOS expression. Although the HU animals did not have systemic hypertension, the shift in gravitational forces are known to markedly raise blood pressure in the cranial circulation (12) . This local rise in the cranial blood pressure may, therefore, be responsible for the observed upregulation of brain nNOS protein expression in HU animals in a manner analogous to that seen in animals with systemic hypertension.
Although Western blot analysis demonstrated upregulations of iNOS and nNOS in the given tissues, it did not identify specific regions or cell types contributing to this phenomenon. Immunohistological studies are required to address this issue.
Numerous authors (7-9, 31, 34, 42) have used the HU model of the present study to simulate microgravity and have compared HU rats to unsuspended, separately caged controls. It must be acknowledged that the stress associated with the tail harness itself could have been responsible for the cardiovascular effects of this model. However, this seems unlikely on the following grounds. Murison et al. (26) argued that the effects of HU are not a result of an increase in stress. He found only an initial transient increase in plasma corticosterone. In addition, the absence of cardiac hypertrophy suggests that the cardiovascular system was not stressed by HU (52) . Kahwaji et al. (16) also found that HU substantially reduced the maximal vascular contraction to norepinephrine but had no effect on that to serotonin. This also argues against a nonspecific effect of HU, such as stress. Although an effect of HU, independent of its hemodynamic effects, is unlikely, this possibility cannot be excluded with certainty. Future experiments comparing harnessed rats in the hindlimb elevated vs. horizontal positions will be required to resolve this issue.
In conclusion, extended exposure to simulated microgravity in the HU animals resulted in marked upregulations of renal, vascular, and cardiac iNOS protein expression and enhanced renal and brain nNOS protein expression and tissue NOx content. Upregulation of iNOS and nNOS expressions in the HU animals was coupled with a depressed pressor response to norepinephrine and an enhanced pressor response to the iNOS inhibitor aminoguanidine. The latter findings provide functional evidence for enhanced iNOS-derived NO activity in the HU animals. Upregulation of iNOS and nNOS may play an important role in chronic adaptation to microgravity and subsequent orthostatic intolerance on reexposure to normal gravity. If true, short-term iNOS inhibition may ameliorate the orthostatic intolerance associated with extended exposure to microgravity. Further studies are needed to explore the usefulness of this therapeutic strategy.
